Blood levels of lactate — a molecule involved in how the body produces energy — may help predict survival and…
Articles by Andrea Lobo, PhD
AB Science has identified a new blood biomarker, produced by certain immune cells, that may help assess the activity…
The Muscular Dystrophy Association (MDA) has launched its annual MDA Shamrocks campaign, described as the nation’s largest St.
The first patient has been dosed in a Phase 1/2 clinical study of VTx-002, an experimental therapy being developed by…
Origami Therapeutics is collaborating with Ipsen to develop experimental therapies designed to remove or correct abnormal proteins that…
Target ALS has announced the launch of its redesigned website, which improves accessibility and highlights its research initiatives to…
Dewpoint Therapeutics has selected a novel small molecule designed to prevent the formation of abnormal TDP-43 protein clumps that…
Mindwalk Holdings has identified and validated antibodies that selectively target an abnormal form of the TDP-43 protein, which is…
The first patient has been dosed in a Phase 2 clinical study testing RAG-17, a therapy being developed by…
The first participants have been dosed in an early Phase 1 clinical study that’s testing NRG5051, a first-in-class treatment…